Floatz logo

Immunoglobulin G4 [236-proline], anti-(human interleukin 1?) (human monoclonal GenSci048 ?4-chain), disulfide with human monoclonal GenSci048 ?-chain, dimer

HCC - Hepatocellular Carcinoma

Tongji Hospitalmonoclonal_antibodyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

520 Active assets in the HCC - Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Adefovir
Bukwang Pharmaceutical
Phase 4BBB
Huaier Granule
Tongji Hospital
Phase 4BBB
Sorafenib
Bayer
Phase 4BBB
Carboplatin
AstraZeneca
Phase 4BB
Theprubicin
RWTH Aachen University
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G4 [236-proline], anti-(human interleukin 1?) (human monoclonal GenSci048 ?4-chain), disulfide with human monoclonal GenSci048 ?-chain, dimer is also rated in:

UnresectableDormant
D
Indicative ·
30 / 100
View asset →
refractory malignant neoplasmDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →